As of 2024-12-13, the Intrinsic Value of Integra Lifesciences Holdings Corp (IART) is
34.38 USD. This IART valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 24.24 USD, the upside of Integra Lifesciences Holdings Corp is
41.80%.
The range of the Intrinsic Value is 15.92 - 96.52 USD
34.38 USD
Intrinsic Value
IART Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
15.92 - 96.52 |
34.38 |
41.8% |
| DCF (Growth 10y) |
22.51 - 109.00 |
42.48 |
75.2% |
| DCF (EBITDA 5y) |
30.68 - 42.95 |
36.09 |
48.9% |
| DCF (EBITDA 10y) |
34.85 - 53.96 |
43.22 |
78.3% |
| Fair Value |
-2.03 - -2.03 |
-2.03 |
-108.39% |
| P/E |
(2.05) - 39.38 |
17.06 |
-29.6% |
| EV/EBITDA |
30.28 - 53.85 |
39.29 |
62.1% |
| EPV |
20.12 - 37.48 |
28.80 |
18.8% |
| DDM - Stable |
(0.55) - (1.67) |
(1.11) |
-104.6% |
| DDM - Multi |
14.89 - 36.18 |
21.23 |
-12.4% |
IART Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
1,870.36 |
| Beta |
1.81 |
| Outstanding shares (mil) |
77.16 |
| Enterprise Value (mil) |
3,461.80 |
| Market risk premium |
4.60% |
| Cost of Equity |
11.17% |
| Cost of Debt |
4.67% |
| WACC |
7.90% |